Muscarinic acetylcholine receptor M1

From WikiMD's WELLNESSPEDIA

(Redirected from M1 receptor)

Overview of the Muscarinic acetylcholine receptor M1


The Muscarinic acetylcholine receptor M1 (CHRM1) is a G protein-coupled receptor that is encoded by the CHRM1 gene in humans. It is one of the five subtypes of muscarinic receptors, which are part of the acetylcholine receptor family. These receptors play a crucial role in the parasympathetic nervous system, mediating various physiological functions.

Function[edit]

The M1 receptor is primarily found in the central nervous system, particularly in the cerebral cortex, hippocampus, and striatum. It is involved in modulating cognitive functions such as learning and memory. Activation of the M1 receptor leads to the stimulation of phospholipase C, resulting in the production of inositol trisphosphate and diacylglycerol, which in turn increase intracellular calcium levels.

Clinical Significance[edit]

The M1 receptor has been implicated in several neurological disorders, including Alzheimer's disease and schizophrenia. It is a target for drug development aimed at improving cognitive deficits associated with these conditions. Agonists of the M1 receptor are being investigated for their potential therapeutic effects in enhancing cognitive function and neuroprotection.

Pharmacology[edit]

M1 receptor agonists and antagonists are used in research to study the receptor's role in various physiological and pathological processes. Pirenzepine is a selective M1 antagonist that has been used to differentiate between M1 and other muscarinic receptor subtypes. The development of selective M1 receptor modulators continues to be an area of active research.

See also[edit]

References[edit]


External links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.